Keyphrases
Metastatic Colorectal Cancer (mCRC)
100%
Resectability
80%
Overall Survival
67%
Quality of Life
58%
Interleukin-6
54%
Metastasectomy
53%
Local Ablative Therapy
48%
YKL-40
45%
Carbohydrate Antigen 19-9 (CA19-9)
45%
Resection
43%
Adjuvant Chemotherapy
41%
Health-related Quality of Life
39%
Carcinoembryonic Antigen
38%
Systemic Therapy
38%
Colorectal Cancer
32%
Adjuvant Therapy
30%
Curative Resection
26%
Older Adults
25%
Overall Survival Rate
25%
Curative Treatment
25%
Multidisciplinary Team
24%
Disease-free Survival
24%
Metastasis
24%
Computed Tomography
22%
Older Patients
22%
Treatment Decisions
22%
Team Assessment
22%
Adult Cancer
19%
Frail Elderly
19%
Colorectal Cancer Patients
19%
Patient Survival
19%
Patient Subgroups
19%
Patients with Colorectal Cancer
19%
Clinical Behavior
19%
Older Cancer Patients
19%
Life Factor
19%
Quality of Survival
19%
Prognostic Role
19%
Subgroup Analysis
19%
Age-related Illnesses
19%
Prospective Intervention Study
19%
Clinical Outcomes
19%
Transient Changes
19%
Primary Tumor Location
19%
Prognostic Factors
19%
Muscle Mass Loss
19%
Survival Outcomes
19%
BRAF Wild Type
19%
Sarcopenic Obesity
19%
Vulnerable Adults
19%
Medicine and Dentistry
Metastatic Colorectal Cancer
98%
Quality of Life
77%
Overall Survival
72%
Colorectal Carcinoma
62%
Surgery
62%
Carcinoembryonic Antigen
58%
Metastasectomy
49%
Interleukin 6
48%
Ablation Therapy
43%
Malignant Neoplasm
42%
Adjuvant Chemotherapy
40%
CA19-9
38%
Systemic Therapy
37%
Metastatic Carcinoma
28%
Adjuvant Therapy
24%
Decision Making
23%
Disease Free Survival
23%
Primary Tumor
23%
Computer Assisted Tomography
21%
Subgroup Analysis
19%
Geriatric Syndrome
19%
Intervention Study
19%
Prognostic Factor
19%
Sarcopenic Obesity
19%
Diseases
17%
Colon
17%
Survival Rate
17%
Hazard Ratio
16%
Biological Marker
14%
Geriatric Assessment
14%
Lung
12%
Recurrent Disease
11%
Frailty
11%
Local Excision
11%
Prevalence
7%
Electrocorticography
7%
Minimal Residual Disease
7%
Cancer Therapy
7%
Population Research
7%
Treatment Group
7%
Long Term Survival
5%
Supportive Care
5%
C Reactive Protein
5%
Urinary Frequency
5%
Population
5%
Proportional Hazards Model
5%
